Structure of at118-l nanobody antagonist in complex with the angiotensin ii type i receptor and losartan
PDB DOI: 10.2210/pdb8th4/pdb
Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Organism(s): Escherichia Coli , Homo Sapiens , Synthetic Construct
Deposited: 2023-07-13 Deposition Author(s): Kruse, A.C. , Skiba, M.A.
Structure of at118-l nanobody antagonist in complex with the angiotensin ii type i receptor and losartan
Primary Citation of Related Structures: 8TH4
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
Type-1 angiotensin II receptor Soluble cytochrome b562 complex | A | 433 | Escherichia Coli , Homo Sapiens , Synthetic Construct | DYKDDDDKILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYDLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLDKLNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKY |
BAG2 Anti-BRIL Fab Heavy Chain | C | 231 | Escherichia Coli , Homo Sapiens , Synthetic Construct | EISEVQLVESGGGLVQPGGSLRLSCAASGFNVVDFSLHWVRQAPGKGLEWVAYISSSSGSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWGYWPGEPWWKAFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD |
BAG2 Anti-BRIL Fab Light Chain | D | 215 | Escherichia Coli , Homo Sapiens , Synthetic Construct | DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYLYYSLVTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
AT118-L Nanobody | B | 140 | Escherichia Coli , Homo Sapiens , Synthetic Construct | EVQLVESGGGLVQPGGSLRLSCAASGYIYSRYRMGWYRQAPGKGREFVAAISGGSSTNYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAAYKIDSNPRVYWGQGTQVTVSSGKPIPNPLLGLDSTLEHHHHHH |
Method: ELECTRON MICROSCOPY
Deposited Date: 2023-07-13 Deposition Author(s): Kruse, A.C. , Skiba, M.A.